ArticleJACC. Basic to translational science2021

Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial.

Thorsten M Leucker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.